FDA Announces New Program to Support the U.S. Food Supply

The Human Foods program will combine the agency’s food safety teams. The Food and Drug Administration (FDA) announced that James Jones will be the first deputy commissioner for…

Read More

FDA Advisors Recommend Blood Pressure Surgery Device

A 12-member panel voted unanimously to approve the item’s safety. A panel of advisors for the Food and Drug Administration (FDA) formally recommended the use of a surgically…

Read More

Appeals Court Rules to Limit Access to Abortion Drug

Mifepristone was not ordered to be removed from the market, and the case goes to Supreme Court. The 5th Circuit Court of Appeals ruled that the Food and…

Read More

FDA Releases Draft of Safety Guidelines for Cosmetics

The agency is taking action under the Modernization of Cosmetics Regulation Act. The U.S. Food and Drug Administration (FDA) recently released preliminary guidelines for cosmetic companies for the…

Read More

FDA and DEA Address Stimulant Medicine Shortage

Agency heads request an increase from manufacturers and for healthcare providers to slow demand. The Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) are taking steps…

Read More

FDA Approves 2nd Opioid Reversal Drug for Over-The-Counter Use

The nasal spray will be available prescription-free by next year. The Food and Drug Administration (FDA) recently approved the opioid overdose reversal drug RiVive for over-the-counter sale, making…

Read More

FDA Approves Gene Therapy for Hemophilia A

Severe cases of the bleeding disorder can be life-threatening. The U.S. Food and Drug Administration (FDA) has granted approval for Roctavian, gene therapy for adults with severe hemophilia…

Read More

FTC and FDA Warn Companies Selling Copycat Delta-8 THC

The joint effort by federal agencies seeks to protect consumers from the potentially harmful ingredient. The Federal Trade Commissioner (FTC) and the Food and Drug Administration (FDA) have…

Read More

FDA Fully Approves Alzheimer’s Drug Leqembi

This traditional approval follows previously fast-tracked authorization. The Food and Drug Administration (FDA) has approved Leqembi for the treatment of Alzheimer’s disease. The FDA included a safety warning…

Read More

FDA Approves First Cell Therapy for Type 1 Diabetes

The treatment was developed to address patients struggling to maintain target blood glucose levels. The U.S. Food and Drug Administration recently granted approval to CellTrans, Inc. for Lantidra.…

Read More

Back to top
FE3